MedCitizens

Founders’ Story: NeuroFlow

Chris Molaro is the CEO and co-founder of NeuroFlow, whose tools enable remote monitoring and behavioral health integration across the continuum of care, including psychology, primary care, and pain management settings.

By MedCity News on November 13, 2018 12:38 pm

Why did you start this company?

“As an Army Veteran and Bronze Star Recipient, I have always been inclined to serve others. That was my mission in Iraq as I led 40 men and women into combat. After returning from active duty, I felt a profound need to help others cope with the residual mental health implications of deployment. I went to the Wharton School at the University of Pennsylvania to earn a degree and commercialize research on behavioral science. This led to meeting my co-founder, Adam Pardes, and founding the original NeuroFlow platform.”

What specific need/problem are you seeking to address in healthcare?

“NeuroFlow’s overarching goal is to provide a standard of care for mental health. The technology helps clinicians to diagnose, treat, and measure patients more efficiently by leveraging data and telehealth. With compliance, patients can get on the path to better health sooner.”

What does your product do? How does it work?

presented by

“NeuroFlow has developed two products: EngageBH™ and IntegrateHealth™. Although the platform has several applications across healthcare settings, its main objective is to connect clinicians and their patients in real-time, using data and monitoring functions to improve patient outcomes. It is both mobile- and web-based, in private practices and major health systems.”

Is this your first healthcare startup? What’s your background in healthcare?

“This is my second startup venture, but first in healthcare. After completing a research project at the University of Pennsylvania’s Neuroscience Department, I began applying business acumen to solving the broad challenges associated with mental health care.”

What is your company’s business model?

“NeuroFlow is selling IntegrateHealth™ to two key buyers: primary care/pain management clinics and enterprise systems, while EngageBH™ is geared towards mental health clinicians. Clients pay based on volume of users (a tier model) and can subscribe as an individual or for a larger body of professionals. The company’s largest engagement is with 300 clinicians.”

Who is your customer? How do you generate revenue?

“Customers fall into one of three buckets: mental health clinics, primary care/pain management clinics and large-scale health systems. As mentioned above, it’s a tier system based on total number of users. Clients can roll-out the platform with a population of clinicians ‘on board’ and expand to meet additional demand.”

Do you have clinical validation for your product?

“NeuroFlow is certified by the Smart Health Innovation Lab, a joint accelerator between Aspire Ventures, Capital Blue Cross, and Penn Medicine Lancaster General Hospital. The 12-week program allowed NeuroFlow to beta test a product in several stages of the healthcare ecosystem, validating it with real users. Once completed, the technology was approved to officially “launch” within the major health system. The platform is also currently being validated in the Philadelphia VA through funding from the National Science Foundation.”

This is a paid member feature of MedCitizens. Please submit here and join!